Results 161 to 170 of about 160,917 (252)

INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome. [PDF]

Toxins (Basel)
Rivas M, Pichel M, Zylberman V, Colonna M, Valerio M, Massa C, Pardo R, Ciocchini AE, Sanguineti S, Roubicek I, Spatz L, Goldbaum FA.   +11 more
europepmc   +1 more source

Tranexamic acid: there's new life in the old drug

Emergency Medicine Journal, 2016
T. Coats
semanticscholar   +1 more source

Immune Tolerance Induction With a Recombinant Factor VIII Fc in Haemophilia A: Data From a Chart Review Study

European Journal of Haematology, Volume 115, Issue 2, Page 134-141, August 2025.
ABSTRACT Objective To report data from an ITI chart review study (NCT03951103) for first‐time and rescue ITI with recombinant factor VIII Fc fusion protein (rFVIIIFc) in persons with haemophilia A. Methods Retrospective and prospective real‐world data are reported from a non‐interventional, multicentre study of patients who had been or were currently ...
Robert Klamroth, Mahasen Al Saleh, Heidi Glosli, Michele Schiavulli, Benoît Guillet, Linda Bystrická, Anton Schönstein, Stefan Lethagen   +7 more
wiley   +1 more source

Orphan GPCRs in Neurodegenerative Disorders: Integrating Structural Biology and Drug Discovery Approaches. [PDF]

Curr Issues Mol Biol
Kim J, Choi C.
europepmc   +1 more source

Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A

Proceedings of the National Academy of Sciences of the United States of America, 2014
Kazuya Yamanaka, Kirk A Reynolds, R. Kersten, K. Ryan, D. Gonzalez, V. Nizet, P. Dorrestein, B. Moore   +7 more
semanticscholar   +1 more source

ROS1 immunohistochemistry as a potential predictive biomarker for ROS1‐targeted therapy in breast cancer: impact of antibody clone selection

Histopathology, Volume 87, Issue 2, Page 223-234, August 2025.
ROS1 antibody clones are not interchangeable in the breast cancer setting and highlight major discordances in ROS1 status according to antibody clone utilised. Aims Invasive lobular carcinoma (ILC) may show targetable vulnerabilities secondary to the characteristic loss of the cell adhesion protein E‐cadherin.
Anna Sokolova, Vaibhavi Joshi, Haarika Chittoory, Michael Walsh, Malcolm Lim, Jamie R Kutasovic, Kaltin Ferguson, Peter T Simpson, Sunil R Lakhani, Amy E McCart Reed   +9 more
wiley   +1 more source

Plant‐derived vesicle‐like nanoparticles in food crops: emerging insights into nutritional biofortification and biomedical applications

Plant Biotechnology Journal, Volume 23, Issue 8, Page 3260-3282, August 2025.
Summary Food crops, as the cornerstone of human nutrition, not only provide essential macronutrients but also encompass a rich spectrum of bioactive compounds that promote health. Of particular significance are underutilized minor crops, which contain unique beneficial components with proven nutraceutical properties. These valuable bioactive components
Jie Wang, Zhaosheng Kong
wiley   +1 more source

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2024. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Aksoyalp ZS, Kayki-Mutlu G, Wojnowski L, Michel MC.   +3 more
europepmc   +1 more source

Integrated Disease Management, Adaptation and Genomics of Fungal Plant Pathogens in Cropping Systems

Plant Pathology, Volume 74, Issue 6, Page 1445-1469, August 2025.
Knowledge of the fungal genome and multifaceted evolutionary forces need to be considered together in understanding and managing agricultural plant pathogen adaptation relative to integrated disease management (IDM) strategies. ABSTRACT Crop production systems contribute significantly to maintaining global food security. These systems often involve the
Hayley Wilson, Ido Bar, Kristy Hobson, Niloofar Vaghefi, Toni Petronitis, Rebecca Ford   +5 more
wiley   +1 more source

Regulatory aspects of optogenetic research and therapy for retinitis pigmentosa under EU law. [PDF]

Front Med Technol
Freise J.
europepmc   +1 more source